Recent advances in the treatment of dermatophytosis and tinea unguium;Ultimos avances en el tratamiento de dermatofitosis y tinea unguium

Revista Iberoamericana de Micologia

Volumn 13, Issue SUPPL. 1, 1996, Pages

  Del Palacio, Amalia ^a   Cuétara, María Soledad ^a   Amor, Elisa ^b   González, Alejandro ^c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL DE MÓSTOLES   (Spain)

^c HÔPITAL DU BOCAGE   (France)

Author keywords

Amorolfine; Eberconazole; Fluconazole; Flutrimazole; Itraconazole; Terbinafine; Tinea capitis; Tinea corporis; Tinea cruris; Tinea pedis

Indexed keywords

EID: 6544273078     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. De Vroey C Epidemiology of ring-worm (dermatophytosis) Sem Dermatol 1985; 4 185-200
2. del Palacio A, Cuétara MS, Roiz MP, López San̄a J, Castejón AM Nuevas perspectivas en el tratamiento de las micosis superficiales Rev Iberoam Micol 1993; 10 93-100.
3. Haroon TS, Hussain I, Mahmood A et al An open clinical pilot study of the efficacy and safety of oral terbinafine in dry, non-inflammatory tinea capitis Br J Dermatol 1992 126 47-50
4. Nejjam F, Zagula M, Cabiac MD Guessous N, Humbert H, Lakhdar H Pilot study of terbinafine in children suffering from tinea capitis Evaluation of efficacy safety and pharmacokinetics Br j Dermatol 1995; 132 98-105
5. Gordon PM, Stankler L Rapid clearing of kerion ringworm with terbinafine Br J Dermatol 1993; 129 503-504
6. Burden AD, Tillman DM, Richardson MD. Human Trichophyton equinum infection treated with terbinafine, Clin Exper Dermatol 1994; 19 359-360
7. Lopez Gomez S, del Palacio A, Van Cutsem J, Cuétara MS, Iglesias L, Rodriguez-Noriega A Itraconazole versus griseofulvin in the treatment of tinea capitis A double-blind randomized study in children Inter J Dermatol 1994 33 743-747.
8. Elewski BE, Weil ML Itraconazole in tinea capitis International Summit on Cutaneous Antifungal Therapy San Francisco, october 22-24, 1993
9. Smith EB Topical antifungal drugs in the treatment of tinea pedis, tinea cruris and tinea corporis J Am Acad Dermatol 1993 28: 24-28
10. Gooskens V, Ponnighaus JM, Clayton Y, Mkandawine P, Sterne JAC Treatment of superficial mycoses in the tropics: Whitfield's ointment versus clotrimazole Int J Dermatol 1994; 33 738-742
11. Hay JR, kinetics of fluconazole in skin and nails Int J Dermatol 1992 31 6-7
12. Faergemann J, Laufen H Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and sweat Clin Exp Dermatol 1993; 18 102-106
13. Suchil P Montero Gei F, Robles M, Perera-Ramirez A Welsh O, Male O Once weekly oral doses of fluconazole 150 mg in the treatment of tinea corporis/cruris and cutaneous candidiasis Clin Exper Dermatol 1992; 17: 397-401
14. Del Aguila R, Montero Gei F, Robles M Perera-Ramirez A, Male O Once weekly oral doses of fluconazole 150 mg in the treatment of tinea pedis Clin Exper Dermatol 1992; 17: 402-406
15. Stengel F, Robles-Soto M, Galimberti R, Suchil P Fluconazole versus ketoconazole in the treatment of dermatophytoses and cutaneous candidiasis Int J Dermatol 1994; 33 726-729
16. Millikan LE, Shrum JP Systemic therapy for mycoses: Changing targets and changing agents Int J Dermatol 1904; 701 33
17. Roberts DT Itraconazole in dermatology J Dermatol Treat 1992 2 155-158
18. Pierard GE, Arrese JE, de Doncker P. Antifungal activity of itraconazole and terbinafine in human stratum corneum. A comparative study. J Am Acad Dermatol 1995; 32: 429-435
19. Van Cutsem J An investigation of the in vitro activity and antifungal spectrum of itraconazole and terbinafine in realation with in vivo efficacy in dermatophytosis and other mycoses J Mycol Med 1994; 4: 137-138
20. Okkola KT Backman JT, Neuvonen PJ Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole Clin Pharmacol Ther 1994; 55: 481-485
21. Drayton J, Dickinson G, Rinaldi MG Coadministration of rifampicin and itraconazole leads to undetectable levels of serum itraconazole Clin Infect Dis 1994; 18 266
22. Tucker RM, Denning DW, Hanson LM. Interaction of azoles with rifampicin, phenytoin and carbamazepine: In vitro and clinical observations Clin Infect Dis 1992; 14: 165-174
23. Anónimo Itraconazole. Med Letter Drugs Ther 1993; 35: 7-9
24. Hostetler JS, Hanson LH, Stevens DA. Effect of hydroxypropil-8-cyclodextrin on efficacy of oral itraconazole in disseminated murine cyptococcosis J Antimicrob Chemother 1993; 32 4
25. Hostetler JS, Hanson LH, Stevens DA Effect of cyclodextrin on the pharmacology of antifungal oral azoles Antimicrob Ag Chemother 1992; 36 477-480
26. Cartledge JD, Midgley J, Youle M, Fisher M, Gazzard BG The use of cyclodextrin solution formulation of itraconazole (ITR-SOL) to treat candidiasis unresponsive to other azole preparations in patients with AIDS IX th International Conference on Aids Berlin, Germany June 7-11, 1993.
27. Wiliemsem M, de Donker P, Willems J, Westenborghs R, Van der Velde V, Heykants J, Van Cutsem J, Cauwenbergh G, Rousseuw D, Postreatment itraconazole levels in the nail J Am Acad Dermatol 1992; 26: 731-735
28. del Palacio A, Van Cutsem J, Löpez S, Roiz MP, Cuétara MS, Iglesias L, Noriega AR, Estudio doble ciego randomizado comparativo con itraconazol y griseofulvina en tinea corporis y tinea cruris Rev Iberam Micol 1993; 10 5-158.
29. Parent D, Decroix J, Heenen M. Clinical experience with short schedules of itraconazole in the treatment of tinea corporis and/or tinea cruris Dermatology 1994, 189 378-381
30. Decroix J. Tinea pedis (mocassin type) treatred with itraconazole. Int J Dermatol 1995; 34 122-124.
31. Berman B, Ellis C, Leyden J, Lowe N et al Efficacy of a 1-week twice daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis J Am Acad Dermatol 1992; 26: 956-960
32. Bergstresser PR, Elewski B, Hanifin J et al. Topical terbinafine and clotrimazole in interdigital tinea pedis A multicenter comparison of cure and relapse rates with 1 and 4 week treatment regimens J Am Acad Dermatol 1993; 28: 648-651.
33. Evans EGV, Williamson DM, Brwon GI, Bowen RG Comparison of terbinafine and clotrimazole in treating tinea pedis. Br Med J 1993; 307: 645-647.
34. Evans EGV A comparison of terbinafine (Lamisil) 1% cream given for one week with clotrimazol (Canesten) 1% cream given for four weeks in the treatment of tinea pedis. Br, J Dermatol 1994; 130 (Suppl 43): 12-14.
35. Evans EGV, Seaman RAJ, James IGV Short duration therapy with terbinafine 1% cream in dermatophyte skin infections Br J Dermatol 1994; 130: 83-87
36. Zaias N, Berman B, Cordero CN et al Efficacy of a 1 week, once daily regimen of terbinafine 1% cream in the treatment of tinea cruris and tinea corporis J Am Acad Dermatol 1993; 29: 646-648
37. Cordero C, de la Rosa I, Espinosa Z, Rojas RJ, Zaias N Short term therapy of tinea cruris/corporis with topical terbinafine J Dermatol Treat 1992; 3 23-24
38. Evans EGV, Shah JM, Joshipura RC. One week treatment of tinea corporis and tinea cruris with terbinafine (Lamisil) 1% cream. a placebo controlled study J Dermatol Treat 1992; 3 181-184.
39. de Keyser P, de Backer M, Massart DL, Westelinck KJ. Two week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day). A double blind muiticentre study Br J Dermatol 1994; 130: 22-25.
40. Hay RJ, Clayton YM A comparison of 2 weeks terbinafine 250 mg/day with 4 weeks of itraconazole 100 mg/day in plantar type tinea pedis 12th Congress of ISHAM, Adelaide, 1994, Marzo 13-18, poster 2.32
41. Hay RJ, Mc Gregor JM, White J, Ryatt KS, Ziegler C, Clayton YM A comparison two weeks terbinafine 250 mg/day with four weeks of itraconazole 100 mg/day in plantar type tinea pedis Br J Dermatol, 1895; 132 604-608
42. Budimulja VV, Kuswadji K, Bramono S et al. A double-blind randomized, stratified controlled study of the treatment of tinea imbricata with oral terbinafine or itraconazole Br J Dermatol 1994; 130: 29-31
43. Albanese G, Di Cintio R, Giorgetti P, Galbiati G, Ciampini M. Recurrent tinea pedis. A double-blind study on the prophylactic use of fenticonazole powder Mycoses 1992, 35: 157-159.
44. Nolting S, Reinel D, Semig G, Reckersczascnka R, Bergstraesser M, Zavag M Amorolfine spray in the treatment of foot mycoses (a dose-finding study) Br J Dermatol 1993; 129 170-174
45. Leyden JJ Progression of interdigital infections from simplex to complex. J Am Acad Dermatol, 1993; 23 7-11
46. Smith EB Topical antifungal drugs in the treatment of tinea pedis, tinea cruris and tinea corporis J Am Acad Dermatol 1993; 28 24-28
47. Odom R Pathophysiology of dermatophyte infectons J Am Acad Dermatol 1993; 28 2-7
48. Font E, Freixes J, Julve J Nuevos antifungicos. Perfil del nuevo antimicótico tópico eberconazol. Rev. Iberam Micol 1995; 12 16-17.
49. Izquierdo I, García Rafanell J. Flutrimazol. Drugs fut 1994; 19: 1-35-
50. del palacio A, Cuetara MS, Rodriguez Noirega A, López S, Iglesias L. A phase II dose finding pilot study Topical treatment of tinea corpons and tinea cruris with eberconazol (was 2160) cream. 2nd. meeting ECMM April 27-29, 1995. Brussels.
51. Alomar A, Videla S, Delgadillo J et al Flutrimazole 1% dermal cream in the treatment of dermatomycoses. A multicentre, double blind, randomized, comparative clinical trial with bifonazole 1% cream Dermatology, 1995; 190 295-300.
52. Binet O, Soto-Melo J, Delgadillo J et al Flutrimazole 1% dermal cream in the treatment of dermatomycoses. A multicentre, double blind, randomized, comparative clinical trial with 1% clotrimazole cream Mycoses, 1995; 37 455-459.
53. del Paiacio A, Cuétara MS, Izquierdo I et al A double blind randomized comparative trial: flutrimazole 1% (solution) versus bifonazole 1% (solution) once daily in dermatomycoses Mycoses, 1995; 38: 395-403.
54. Hay RJ Onychomycoses. Agents of choice Dermal Clin 1993; 11 11-169
55. Barranco V. New approaches to the diagnosis and manegement of onychomycoses Int J Dermatol 1994; 33 292-299
56. Pierard GE, Arrese Estrada J, Pierard Franchimont C. Treatment of Onychomycoses Traditional approaches J Am Acad Dermatol 1993; 29 41-45.
57. Rouseeuw D, De Doncker P. New approaches to the treatment of anychomycoses J Am Acad Dermatol 1993; 29 45-50
58. Williams HC The epidemiology of onychomycoses in Britain Br J Dermatol 1993; 129 101-109
59. Sais G, Jucqia A, Peynf J Prevalence of dermatophyte onychomycoses in Spain. A Cross-Sectional Study Br J Dermatol, 1995; 132: 758-761
60. del Palacio A, Cuétara MS, Castejón A Avances en el tratamiento de onicomicosis y dermatofitosis Medicine 1994; 6 24-36
61. Hay RJ. Risk/benefit ratio of modern antifungal therapy Focus on hepatic reactions J Am Acad Dermatol 1993; 29 (suppl 1) 50-54
62. Polak A Preclinical data and mode of action of amorolfine. Dermatology 1992; 184 3-7.
63. Polak A Amorolfine A review of its mode of action and in vitro and in vitro antifungal activity. JAMA SEA 1993; 9 11-10.
64. Polak A Kinetics of amorolfine in human nails Mycoses 1993; 36: 101-103
65. Polak A Combination of amorolfine with various antifungal drugs in dermatophosis Mycoses 1993;36: 43-49
66. Feuilhade M, Baran R, Goetmann S et al Interest of the combination of 5% amorofilne nail tacquer + terbinafine tablet in the treatment of foot dermathophytes onychomycoses with involved matrix 2nd meeting ECMM April 27-29, 1995, Brussels
67. Lauharania J, Zaung M, Polak A, Reinel D. Combination of amorolfine with griseofulvin in vitro activity and clinical results in onychomycoses JAMA SEA 1993; 9: 23-27
68. Zaug M Amorolfine nail lacquer Once weekly application in onychomycoses. JAMA SEA 1993; 9: 19-22
69. Reinel D. Topical treatment of onychomycoses with amorolfine nail-lacquer: Comparative efficacy and tolerancy of once and twice weekly use. Dermatology 1992; 184 21-24.
70. Villars VV, Jones TC. Clinical use of oral and topical terbinafine in the treatment of fungal diseases En. Rippon JW, Fromtling RA eds. Cutaneous antifungal agents. New York Marcel Dekker, 1993; 151-168
71. Willemsen M, De Doncker P, Willems MD et al. Post treatment itraconazole levels in the nail J Am Acad Dermatol 1992; 26 731-735.
72. Roseeuw P, de Doncker P New therapeutic concepts for the treatment of onychomycoses J Eur Acad Dermatol Venereol 1993; 2 24-38.
73. Hann SK, Kim JB, Im S, Han KH, Park YK Itraconazole induced acute hepatitis Br. J Dermatol 1993; 129 500
74. Arenas R, Dominguez Cherit J, Fernández L Open randomized comparison of itraconazole versus terbinafine in onychomycoses Int J Dermatol 1995; 34: 138-143
75. Morelli A, Stinchi C, La Placa M, Tosti A XIth Congress of ISHAM Adelaide, March 13-18, 1994
76. Einarson TR, Ankian SR, Shear NH Cost effectiveness analysis for onychomycoses therapy in Canada from a goverment perspective. Br J Dermatol 1994; 130: 32-34
77. Honig PJ, Caputo GL, Leyden JJ, Mc Ginley K, Selbst SM, Gravey RM. Treatment of kerions Pediatr Dermatol 1994; 11 69-71.
78. Nolting S, Rogalla K Double blind comparison of miconazole/corticosteroid combination versus miconazole in inflammatory dermatomycoses. Int J Dermatol 1995; 34: 125-128
79. Weitzman I, Summerbell R. The dermatophytes Clin Microbiol Rev 1995; 8 240-259.